Age (years) |
71 (15.5) |
Male |
89.5% (n=34) |
Duration of atrial flutter (months) |
8.5 (8) |
Hypertension |
23.7% (n=9) |
Diabetes |
15.8% (n=6) |
Smoking history |
13.2% (n=5) |
Ischaemic heart disease (previous PCI or CABG) |
10.5%
(n=4) |
Congenital heart disease |
2.6% (n=1; coarctation of the
aorta) |
Beta blocker |
86.8% (n=33) |
Class III anti-arrhythmic drug |
15.8% (n=6) |
Anticoagulated with DOAC (remainder warfarin) |
92.1%
(n=35) |
LV ejection fraction (%) |
55 (10) |
Baseline ablation data |
Baseline ablation
data |
General anaesthetic |
23.7% (n=9) |
Procedure started in sinus rhythm |
23.7% (n=9) |
Long sheath used |
36.8% (n=14) |
Procedure time (minutes) |
61.4±37.1 |
Fluoroscopy time (minutes) |
2.7±4.7 |
Dose area product (cGy/cm2) |
78.6±254 |